A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study
Katie Wakeley(South Shore Hospital), Marion Piedmonte(Cleveland Clinic), Peter E. Schwartz(Yale University), Jennifer T. Loud(National Cancer Institute), Martee L. Hensley(Memorial Sloan Kettering Cancer Center), Lori M. Minasian(National Cancer Institute), John F. Boggess(University of Kentucky), Gustavo Rodríguez(The University of Texas at El Paso), Mitchell H. Gail(National Institutes of Health), Jack Basil(St. Elizabeth Healthcare), Mark H. Greene(Cancer Institute (WIA)), Dave Alberts(Arizona Oncology), Joseph L. Kelley(Magee-Womens Hospital), Phuong L. Mai(Indiana University School of Medicine), Zoe Miner(Gynecologic Oncology Group), Stephen Skates(Harvard University Press)
Cited by 0
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries
|Nature Genetics|2010|709
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
|Arthritis & Rheumatism|2002|661